You-Yu Lin Selected Research

Hepatitis B e Antigens

12/2021	Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients.
6/2021	Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients.
6/2021	Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

You-Yu Lin Research Topics

Disease

9	Neoplasms (Cancer) 01/2021 - 02/2014
4	Hepatitis B 01/2022 - 01/2019
4	Chronic Hepatitis B 06/2021 - 08/2014
2	Infections 01/2022 - 06/2021
2	Glioma (Gliomas) 01/2021 - 11/2019
2	Leukoaraiosis 02/2017 - 01/2013
1	Reinfection 01/2022
1	Hepatitis 06/2021
1	Residual Neoplasm 12/2020
1	Liver Neoplasms (Liver Cancer) 12/2020
1	Chronic Hepatitis C 03/2020
1	Syphilis 03/2019
1	Carcinogenesis 01/2019
1	Stomach Neoplasms (Stomach Cancer) 02/2017
1	Diabetes Mellitus 02/2017
1	Hypertension (High Blood Pressure) 02/2017
1	Cerebral Infarction 01/2015
1	Pathologic Constriction (Stenosis) 01/2015
1	Atherosclerosis 01/2015
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 01/2015
1	Ischemic Stroke 01/2013

Drug/Important Bio-Agent (IBA)

3	Hepatitis B e AntigensIBA 12/2021 - 06/2021
3	Pharmaceutical PreparationsIBA 01/2021 - 02/2017
3	Proteins (Proteins, Gene)FDA Link 11/2019 - 01/2019
2	AntigensIBA 12/2021 - 06/2021
2	SaponinsIBA 01/2018 - 02/2014
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	T140 peptideIBA 01/2022
1	hepatitis B hyperimmune globulinIBA 01/2022
1	InterferonsIBA 06/2021
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2021
1	NucleotidesIBA 06/2021
1	DNA (Deoxyribonucleic Acid)IBA 12/2020
1	Biomarkers (Surrogate Marker)IBA 12/2020
1	VaccinesIBA 05/2020
1	sofosbuvir drug combination ledipasvirIBA 03/2020
1	Glucosamine (Dona)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 11/2019
1	Small Interfering RNA (siRNA)IBA 11/2019
1	Penicillins (Penicillin)FDA Link 03/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019
1	Cyclin DIBA 02/2017
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2017
1	Sirtuin 1IBA 02/2017
1	PlatinumIBA 02/2017
1	tumor-associated NADH oxidaseIBA 02/2017
1	NAD (NADH)IBA 02/2017
1	HomocysteineIBA 02/2017
1	Fibrinogen (Factor I)FDA Link 02/2017
1	Uric Acid (Urate)IBA 02/2017
1	fibrin fragment D (D-dimer)IBA 02/2017
1	Apolipoproteins B (ApoB)IBA 01/2015
1	ApolipoproteinsIBA 01/2015
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2015
1	Circular DNAIBA 08/2014
1	Antiviral Agents (Antivirals)IBA 08/2014
1	TriterpenesIBA 02/2014
1	Oleanolic AcidIBA 02/2014
1	AcetylglucosamineIBA 02/2014
1	Blood Glucose (Blood Sugar)IBA 01/2013
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2013

Therapy/Procedure

5	Therapeutics 06/2021 - 08/2014
1	Liver Transplantation 01/2022